Abstract
Chromosome deletions are the most common genetic events observed in cancer1–4. These deletions are generally thought to reflect the existence of a tumour suppressor gene within the lost region5. However, when the lost region does not precisely coincide with a hereditary cancer locus, identification of the putative tumour suppressor gene (target of the deletion) can be problematic. For example, previous studies have demonstrated that chromosome 18q is lost in over 60% of colorectal as well as in other cancers, but the lost region could not be precisely determined6–8. Here we present a rigorous strategy for mapping and evaluating allelic deletions in sporadic tumours, and apply it to the evaluation of chromosome 18 in colorectal cancers. Using this approach, we define a minimally lost region (MLR) on chromosome 18q21, which contains at least two candidate tumour suppressor genes, DPC4 and DCC. The analysis further suggested genetic heterogeneity, with DPC4 the deletion target in up to a third of the cases and DCC or a neighbouring gene the target in the remaining tumours.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Mitelman, F. in Catalog of chromosome aberrations in cancer (Wiley-Liss, 1991).
Sandberg, A.A. & Chen, Z. Cancer cytogenetics and molecular genetics: detection and therapeutic strategy. In Vivo 8, 807–818 (1994).
Olopade, O.I. & Rowley, J.D. in Cancer Medicine (eds. Holland, J.F. et al) 99–120 (Lea & Febiger, Philadelphia, 1993).
Cavenee, W.K. & White, R.L. The genetic basis of cancer. Sci. Am. 272, 72–79 (1995).
Knudson, A.G. Antioncogenes and human cancer. Proc. Natl. Acad. Sci. USA 90, 10914–10921 (1993).
Vogelstein, B. et al. Genetic alterations during colorectal-tumor development. N Engl. J. Med. 319, 525–532 (1988).
Muleris, M., Salmon, R.J., Zafrani, B., Girodet, J. & Dutrillaux, B. Consistent deficiencies of chromosome 18 and of the short arm of chromosome 17 in eleven cases of human large bowel cancer: a possible recessive determinism. Ann. Genet. 28, 206–213 (1985).
Cho, K.R. et al. The DCC gene: structural analysis and mutations in colorectal carcinomas. Genomics 19, 525–531 (1994).
lonov, Y., Peinado, M.A., Malkhosyan, S., Shibata, D. & Perucho, M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363, 558–561 (1993).
Thibodeau, S.N., Bren, G. & Schaid, D. Microsatellite instability in cancer of the proximal colon. Science 260, 816–819 (1993).
Aaltonen, L.A. et al. Clues to the pathogenesis of familial colorectal cancer. Science 260, 812–816 (1993).
Marra, G. & Boland, C.R. Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J. Natl. Cancer Inst. 87, 1114–1125 (1995).
Cho, K.R. & Fearon, E.R. DCC: linking tumor suppressor genes and altered cell surface interactions in cancer?. Curr. Opin. Genet. Dev. 5, 72–78 (1995).
Hahn, S.A. et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271, 350–353 (1996).
Rojas, K., Silverman, G.A., Hudson, J.R., & Overhauser, J. Integration of the 1993-94 Genethon genetic linkage map for chromosome 18 with the physical map using a somatic cell hybrid mapping panel. Genomics 25, 329–330 (1995).
Powell, S.M. et al. Molecular diagnosis of familial adenomatous polyposis. N. Engl. J. Med. 329, 1982–1987 (1993).
van der Luijt, R. et al. Rapid detection of translation-terminating mutations at the adenomatous polyposis coli (APC) gene by direct protein truncation test. Genomics 20, 1–4 (1994).
Riggins, G.J. et al. Mad-related genes in the human. Nature Genet. 13, 347–349 (1996).
Akiyama, M. et al. Mutation frequency in human blood cells increases with age. Mutat Res. 338, 141–149 (1995).
Loeb, L.A. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 51, 3075–3079 (1991).
Martin, G.M. et al. Somatic mutations are frequent and increase with age in human kidney epithelial cells. Hum. Mol. Genet. 5, 215–221 (1996).
Pietenpol, J.A. et al. Paradoxical inhibition of solid tumor cell growth by bcl2. Cancer Res. 54, 3714–3717 (1994).
Willson, J. Cell culture of human colon adenomas and carcinomas. Cancer Res. 47, 2704–2713 (1987).
Markowitz, S. et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268, 1336–1338 (1995).
Jen, J. et al. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N. Engl. J. Med. 331, 213–221 (1994).
Hackman, P., Gabbani, G., Osterholm, A.M., Hellgren, D. & Lambert, B. Spontaneous length variation in microsatellite DMA from human t-cell clones. Genes Chrom. Cancer 14, 215–219 (1995).
Ried, T. et al. Specific metaphase and interphase detection of the breakpoint region in 8q24 of Burkitt lymphoma cells by triple-color fluorescence in situ hybridization. Genes Chromosom. Cancer 4, 69–74 (1992).
Lichter, P. & Cremer, T. in Human Cytogenetics: A Practical Approach (eds Rooney, D.E. & Czepulkowski, B.H.) 157–192 (IRL, Oxford, 1992).
van den Engh, G., Sachs, R. & Trask, B.J. Estimating genomic distance from DNA sequence location in cell nuclei by a random walk model. Science 257, 1410–1412 (1992).
Lengauer, C. et al. Large-scale isolation of human 1 p36-specific p1 clones and their use for fluorescence in situ hybridization. Genet. Anal. Tech. Appl. 11, 140–147 (1994).
Papadopoulos, N. et al. Mutation of a mutL homolog in hereditary colon cancer. Science 263, 1625–1629 (1994).
Leach, F.S. et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75, 1215–1225 (1993).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Thiagalingam, S., Lengauer, C., Leach, F. et al. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet 13, 343–346 (1996). https://doi.org/10.1038/ng0796-343
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng0796-343
This article is cited by
-
TGFβ1 rs1800469 and SMAD4 rs10502913 polymorphisms and genetic susceptibility to colorectal cancer in Bangladeshi population
Molecular Biology Reports (2023)
-
Bromodomain and extra-terminal motif (BET) inhibition is synthetic lethal with loss of SMAD4 in colorectal cancer cells via restoring the loss of MYC repression
Oncogene (2021)
-
Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant
Oncogene (2020)
-
Precision medicine review: rare driver mutations and their biophysical classification
Biophysical Reviews (2019)
-
Nafamostat mesilate negatively regulates the metastasis of triple-negative breast cancer cells
Archives of Pharmacal Research (2018)